Hostname: page-component-84b7d79bbc-2l2gl Total loading time: 0 Render date: 2024-07-28T16:26:04.593Z Has data issue: false hasContentIssue false
  • English
  • Français

COVID-19 vaccine hesitancy among breast cancer patients in East Avenue Medical Center

Published online by Cambridge University Press:  01 September 2022

O.K. Castro  and
S.F. Ty
O.K. Castro*
Affiliation:
East Avenue Medical Center, Internal Medicine, Quezon City, Philippines
S.F. Ty
Affiliation:
East Avenue Medical Center, Internal Medicine, Quezon City, Philippines
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Vaccine hesitancy has been an ongoing complex public issue in the Philippines posing threats to progress against preventable outbreaks and significant morbidity and mortality from COVID-19. Patients with cancer were not included in the initial vaccine trials against COVID-19 hence the plausible explanation behind vaccine hesitancy in this population. This study attempts to determine the factors affecting a patient diagnosed with breast cancer to receive COVID-19 vaccine based on constructs from the Health Beliefs Model (HBM).

Objectives

To determine the factors affecting a Filipino diagnosed with breast cancer to receive COVID-19 vaccine, namely; perceived susceptibility and severity to COVID-19 and perceived benefits and barriers to getting a vaccination against COVID-19.

Methods

A single- center, descriptive, cross-sectional study in patients diagnosed with breast cancer was conducted to assess COVID-19 vaccine hesitancy.

Results

A total of 85 eligible breast cancer patients were included in the analyses. Age, socio-economic factors, and presence of co-morbidities and metastasis were not significantly associated with COVID-19 vaccine hesitancy. Concerns on efficacy, safety, faulty or fake vaccine, as well as if the vaccine was taken by many in the public were significantly associated with hesitancy (p <0.05) when taken as individual factors. The perception of COVID-19 vaccine safety under the perceived barriers construct was found to be the only significant factor to predict vaccine hesitancy (OR= 4.737, CI 1.75, 12.82).

Conclusions

Interventions that focus on perceived barriers are most crucial in order to increase vaccination rate among breast cancer patients.

Disclosure

No significant relationships.

Keywords

Covid-19breast cancervaccine hesitancy
Type
Abstract
Information
European Psychiatry , Volume 65 , Special Issue S1: Abstracts of the 30th European Congress of Psychiatry , June 2022 , pp. S310
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.